Linkage analysis of susceptibility to hyperoxia -: Nrf2 is a candidate gene

被引:154
作者
Cho, HY [1 ]
Jedlicka, AE [1 ]
Reddy, SPM [1 ]
Zhang, LY [1 ]
Kensler, TW [1 ]
Kleeberger, SR [1 ]
机构
[1] Johns Hopkins Univ, Sch Publ Hlth, Dept Environm Hlth Sci, Div Physiol, Baltimore, MD 21205 USA
关键词
D O I
10.1165/ajrcmb.26.1.4536
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A strong role for reactive oxygen species (ROS) has been proposed in the pathogenesis of a number of lung diseases. Hyperoxia (> 95% oxygen) generates ROS and extensive lung damage, and has been used as a model of oxidant injury. However, the precise mechanisms of hyperoxia-induced toxicity have not been completely clarified. This study was designed to identify hyperoxia susceptibility genes in C57BL/6J (susceptible) and C3H/HeJ (resistant) mice. The quantitative phenotypes used for this analysis were pulmonary inflammatory cell influx, epithelial cell sloughing, and hyperpermeability. Genome-wide linkage analyses of intercross (F-2) and recombinant inbred cohorts identified significant and suggestive quantitative trait loci on chromosomes 2 (hyperoxia susceptibility locus 1 [Hsl1]) and 3 (Hsl2), respectively. Comparative mapping of Hsl1 identified a strong candidate gene, Nfe2/2 (nuclear factor, erythroid derived 2, like 2 or Nrf2) that encodes a transcription factor NRF2 which regulates antioxidant and phase 2 gene expression. Strain-specific variation in lung Nrf2 messenger RNA expression and a T --> C substitution in the B6 Nrf2 promoter that cosegregated with susceptibility phenotypes in F-2 animals supported Nrf2 as a candidate gene. Results from this study have important implications for understanding the mechanisms through which oxidants mediate the pathogenesis of lung disease.
引用
收藏
页码:42 / 51
页数:10
相关论文
共 58 条
  • [11] HLA-A2 AND CHRONIC LUNG-DISEASE IN NEONATES
    CLARK, DA
    PINCUS, LG
    OLIPHANT, M
    HUBBELL, C
    OATES, RP
    DAVEY, FR
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1982, 248 (15): : 1868 - 1869
  • [12] CLARK JM, 1971, PHARMACOL REV, V23, P37
  • [13] TOLERANCE OF RATS TO HYPEROXIA - LUNG ANTIOXIDANT ENZYME GENE-EXPRESSION
    CLERCH, LB
    MASSARO, D
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (02) : 499 - 508
  • [14] CRAPO JD, 1986, ANNU REV PHYSIOL, V48, P721
  • [15] CRAPO JD, 1980, AM REV RESPIR DIS, V122, P123
  • [16] Gene therapy for oxidant injury-related diseases:: Adenovirus-mediated transfer of superoxide dismutase and catalase cDNAs protects against hyperoxia but not against ischemia-reperfusion lung injury
    Danel, C
    Erzurum, SC
    Prayssac, P
    Eissa, NT
    Crystal, RG
    Hervé, P
    Baudet, B
    Mazmanian, M
    Lemarchand, P
    [J]. HUMAN GENE THERAPY, 1998, 9 (10) : 1487 - 1496
  • [17] DENKE SM, 1980, NEW ENGL J MED, V303, P76
  • [18] High sensitivity of Nrf2 knockout mice to acetaminophen hepatotoxicity associated with decreased expression of ARE-regulated drug metabolizing enzymes and antioxidant genes
    Enomoto, A
    Itoh, K
    Nagayoshi, E
    Haruta, J
    Kimura, T
    O'Connor, T
    Harada, T
    Yamamoto, M
    [J]. TOXICOLOGICAL SCIENCES, 2001, 59 (01) : 169 - 177
  • [19] Antioxidant functions of sulforaphane: a potent inducer of phase II detoxication enzymes
    Fahey, JW
    Talalay, P
    [J]. FOOD AND CHEMICAL TOXICOLOGY, 1999, 37 (9-10) : 973 - 979
  • [20] Extracellular superoxide dismutase in the airways of transgenic mice reduces inflammation and attenuates lung toxicity following hyperoxia
    Folz, RJ
    Abushamaa, AM
    Suliman, HB
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (07) : 1055 - 1066